DANIEL DESALVO to Blood Glucose Self-Monitoring
This is a "connection" page, showing publications DANIEL DESALVO has written about Blood Glucose Self-Monitoring.
Connection Strength
6.404
-
Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes. Pediatr Diabetes. 2023; 2023:4751595.
Score: 0.781
-
Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study. J Diabetes Res. 2018; 2018:5162162.
Score: 0.543
-
Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes. 2018 11; 19(7):1271-1275.
Score: 0.540
-
Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes. Diabetes Care. 2015 Oct; 38(10):e166-7.
Score: 0.443
-
Accuracy evaluation of blood glucose monitoring systems in children on overnight closed-loop control. J Diabetes Sci Technol. 2014 Sep; 8(5):969-73.
Score: 0.406
-
Continuous glucose monitoring: current use and future directions. Curr Diab Rep. 2013 Oct; 13(5):657-62.
Score: 0.389
-
A multimodal physiological dataset for non-invasive blood glucose estimation. Sci Data. 2025 Nov 19; 12(1):1822.
Score: 0.225
-
Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes. Diabetes Care. 2025 May 01; 48(5):768-775.
Score: 0.217
-
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring. Horm Res Paediatr. 2024; 97(6):615-635.
Score: 0.213
-
Real-World Insights Into Hypoglycemia Risk While Driving in Teens and Young Adults With Type 1 Diabetes. Pediatr Diabetes. 2025; 2025:5053872.
Score: 0.213
-
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod? 5 Automated Insulin Delivery System. Diabetes Technol Ther. 2024 06; 26(6):383-393.
Score: 0.200
-
Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results. Pediatr Diabetes. 2023; 2023:6718115.
Score: 0.195
-
Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial. Pediatr Diabetes. 2023; 2023:6906023.
Score: 0.194
-
Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. Diabetes Technol Ther. 2022 12; 24(12):920-924.
Score: 0.180
-
Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative. Diabetes Care. 2022 08 01; 45(8):e118-e119.
Score: 0.179
-
Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE Study. J Diabetes Sci Technol. 2023 Jul; 17(4):976-987.
Score: 0.175
-
Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2023 03; 17(2):322-328.
Score: 0.169
-
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 06 16; 323(23):2388-2396.
Score: 0.155
-
Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring. Diabet Med. 2019 11; 36(11):1508-1510.
Score: 0.145
-
Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technol Ther. 2019 09; 21(9):493-498.
Score: 0.145
-
Effect of acetaminophen on CGM glucose in an outpatient setting. Diabetes Care. 2015 Oct; 38(10):e158-9.
Score: 0.111
-
Remote glucose monitoring in camp setting reduces the risk of prolonged nocturnal hypoglycemia. Diabetes Technol Ther. 2014 01; 16(1):1-7.
Score: 0.098
-
SCI - U: Validation of an updated Self-Care Inventory for contemporary diabetes management in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2025 Jun; 224:112218.
Score: 0.054
-
Real-World Evidence of Omnipod? 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technol Ther. 2024 08; 26(8):514-525.
Score: 0.050
-
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2024 01; 26(1):11-23.
Score: 0.049
-
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice. Endocr Rev. 2023 03 04; 44(2):254-280.
Score: 0.047
-
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring. Pediatr Diabetes. 2022 12; 23(8):1390-1405.
Score: 0.046
-
A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System. Diabetes Technol Ther. 2021 05; 23(5):367-375.
Score: 0.041
-
Feature-Based Machine Learning Model for Real-Time Hypoglycemia Prediction. J Diabetes Sci Technol. 2021 07; 15(4):842-855.
Score: 0.039
-
Characteristics of adult- compared to childhood-onset type 1 diabetes. Diabet Med. 2020 12; 37(12):2109-2115.
Score: 0.038
-
Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study. Diabet Med. 2020 08; 37(8):1308-1315.
Score: 0.038
-
Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers. Diabetes Technol Ther. 2017 06; 19(6):363-369.
Score: 0.031
-
Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes. J Diabetes Sci Technol. 2016 11; 10(6):1268-1276.
Score: 0.030
-
Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care. 2014 Aug; 37(8):2310-6.
Score: 0.025